For combined epicondylitis, consider increasing total daily dose to 0.5 mg and alternating injection sites between medial and lateral regions
Typically, an initial series of treatments may be recommended, ranging from once to twice a week over four to eight weeks
The total number of GLP-1-prescribing providers increased by 228% from July 2020 to May 2023
Over time, factors such as age, lifestyle, genetics, previous injury, inflammation, and biomechanical instability can lead to collagen breakdown and slow the process of healthy collagen synthesis
Cautions and precautions include: History of pancreatitis (discontinue if pancreatitis is suspected) Type 1 diabetes or diabetic ketoacidosis (not indicated) Severe gastrointestinal disease including gastroparesis Gallbladder disease (increased risk with GLP-1 therapy) Diabetic retinopathy (monitor for worsening with rapid glycaemic improvement, particularly with semaglutide) Regarding renal impairment , most GLP-1 agonists (semaglutide, liraglutide, dulaglutide) require no dose adjustment
Ideal for daily use, its hypoallergenic formula makes it suitable for all skin types, including sensitive skin